Journal article icon

Journal article

Ablation of CCL17 ‐positive hippocampal neurons induces inflammation‐dependent epilepsy

Abstract:
Objective: Neuronal cell death and neuroinflammation are characteristic features of epilepsy, but it remains unclear whether neuronal cell death as such is causative for the development of epileptic seizures. To test this hypothesis, we established a novel mouse line permitting inducible ablation of pyramidal neurons by inserting simian diphtheria toxin (DT) receptor (DTR) cDNA into the Ccl17 locus. The chemokine CCL17 is expressed in pyramidal CA1 neurons in adult mice controlling microglial quiescence. Methods: Seizure activity in CCL17‐DTR mice was analyzed by electroencephalographic recordings following treatment with DT for 3 consecutive days. Neuroinflammation and neuronal cell death were evaluated by (immuno)histochemistry. Pharmacological inhibition of TNFR1 signaling was achieved by treatment with XPro1595, a dominant‐negative inhibitor of soluble tumor necrosis factor. Results: Neuronal cell death was detectable 7 days (d7) after the first DT injection in heterozygous CCL17‐DTR mice. Spontaneous epileptic seizures were observed in the vast majority of mice, often with an initial peak at d6–9, followed by a period of reduced activity and a gradual increase during the 1‐month observation period. Microglial reactivity was overt from d5 after DT administration not only in the CA1 region but also in the CA2/CA3 area, shortly followed by astrogliosis. Reactive microgliosis and astrogliosis persisted until d30 and, together with neuronal loss and stratum radiatum shrinkage, reflected important features of human hippocampal sclerosis. Granule cell dispersion was detectable only 3 months after DT treatment. Application of XPro1595 significantly reduced chronic seizure burden without affecting the development of hippocampal sclerosis. Significance: In conclusion, our data demonstrate that sterile pyramidal neuronal death is sufficient to cause epilepsy in the absence of other pathological processes. The CCL17‐DTR mouse line may thus be a valuable model for further mechanistic studies on epilepsy and assessment of antiseizure medication.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/epi.18200

Authors


More by this author
Role:
Author
ORCID:
0009-0000-3445-6397
More by this author
Role:
Author
ORCID:
0000-0003-4749-5162
More by this author
Role:
Author
ORCID:
0000-0003-2087-2984
More by this author
Role:
Author
ORCID:
0000-0003-2076-2160


More from this funder
Funder identifier:
https://ror.org/018mejw64
More from this funder
Funder identifier:
https://ror.org/043j0f473
More from this funder
Funder identifier:
https://ror.org/0472cxd90
More from this funder
Funder identifier:
https://ror.org/01cwqze88


Publisher:
Wiley
Journal:
Epilepsia: Official journal of the International League Against Epilepsy More from this journal
Publication date:
2024-11-28
Acceptance date:
2024-11-13
DOI:
EISSN:
1528-1167
ISSN:
1528-1167 and 0013-9580


Language:
English
Keywords:
Source identifiers:
2457455
Deposit date:
2024-11-28
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP